Showing results (881-890 of 992) with videos related to

Sort By:
Pageof 100
Therapeutic Advances in Respiratory Disease|May 23, 2024
Impact of lumacaftor/ivacaftor on the bacterial and fungal respiratory pathogens in cystic fibrosis: a prospective multicenter cohort study in SwedenMahasin Al Shakirchi, Kimmo Sorjonen, Lena Hjelte, et al.
Therapeutic Advances in Respiratory Disease|June 15, 2024
Prescriptions of opioid-containing drugs in patients with chronic coughMichael Weiner, Ziyue Liu, Jonathan Schelfhout, et al.
Therapeutic Advances in Respiratory Disease|June 18, 2024
Basic assessment of chronic cough in primary care and referral pathways of patients to different specialists: plain language summary of publicationChristian Domingo, Jaime Gonzálvez-Rey, Ignacio Dávila, et al.
Therapeutic Advances in Respiratory Disease|October 27, 2023
An unexpected encounter and outcome between endobronchial lipoma and carcinoma: a case report and literature reviewYang Yang, Jun Liu, Songkuan Chen, et al.
Therapeutic Advances in Respiratory Disease|July 13, 2023
Long-term efficacy and safety of the Dumon stent for treatment of benign airway stenosisLi-Qin Lin, Di-Fei Chen, Hong-Kai Wu, et al.
Therapeutic Advances in Respiratory Disease|March 15, 2018
Single-inhaler triple therapy utilizing the once-daily combination of fluticasone furoate, umeclidinium and vilanterol in the management of COPD: the current evidence base and future prospectsMario Malerba, Matteo Nardin, Giuseppe Santini, et al.
Therapeutic Advances in Respiratory Disease|September 11, 2020
Derivation and validation of a prediction rule for mortality of patients with respiratory virus-related pneumonia (RV-p score)Liang Chen, Xiudi Han, YanLi Li, et al.
Therapeutic Advances in Respiratory Disease|September 15, 2020
Prognostic significance of forced vital capacity decline prior to and following antifibrotic therapy in idiopathic pulmonary fibrosisYuya Aono, Yutaro Nakamura, Masato Kono, et al.
Therapeutic Advances in Respiratory Disease|March 14, 2020
Comorbidity in idiopathic pulmonary fibrosis - what can biomarkers tell us?Tiago M Alfaro, Carlos Robalo Cordeiro
Therapeutic Advances in Respiratory Disease|December 24, 2019
Systematic review and network meta-analysis of the efficacy and safety of glycopyrrolate/formoterol fumarate metered dose inhaler in comparison with other long-acting muscarinic antagonist/long-acting β2-agonist fixed-dose combinations in COPDMohd Kashif Siddiqui, Pragya Shukla, Martin Jenkins, et al.
Pageof 100